INVICTA2025-10-012026-03-31INVICTA2026-03-31INVICTA2025-03-31INVICTA2025-04-012026-03-31INVICTA2025-10-012026-03-31in-capmkt:OtherExpenses1MemberINVICTA2025-04-012026-03-31in-capmkt:OtherExpenses1MemberINVICTA2026-03-31OtherNoncurrentAssetsDomain1INVICTA2026-03-31OtherCurrentAssetsDomain1INVICTA2026-03-31OtherCurrentLiabilitiesDomain1INVICTA2025-10-012026-03-31AuditorDomain1INVICTA2026-03-31Statement1INVICTA2025-10-012026-03-31Statement1INVICTA2026-03-31StatementDynamic1I1Statement1INVICTA2026-03-31StatementDynamic1I2Statement1INVICTA2026-03-31StatementDynamic1I3Statement1iso4217:INRxbrli:pureiso4217:INRxbrli:shares000000INVICTANOTLISTEDINE0XJ501010INVICTA DIAGNOSTIC LIMITEDSMEEquity2025-04-012026-03-312026-05-182026-05-13INRLakhsHalf YearlyYearlySingle segmentDiagnostic Services2026-05-1811:00:002026-05-1813:15:00trueCash Flow IndirectDeclaration of unmodified opiniontruefalseNANAfalsetrue2025-06-19https://drive.google.com/file/d/1l5W2f5CBT6NTaQ_m_Zz7gSdBfrNeMLr1/view?usp=sharingtrue1falseNo Disclosure for the default on Loans and Debt Securities is applicable to the company2025-10-012026-03-31AuditedStandalone9653400025300009906400008810000-2800017103000225000905700039866000750330002403100002403100045640008410005405000018626000000018626000018626000125720000101.871.87001.871.87Notes <BR> 1 The above statements were reviewed and recommended by the Audit Committee and approved by the Board of Directors at their respective meetings held on 18th May 2026. <BR> 2 These financial results have been prepared in accordance with Accounting Standard ('AS') prescribed under Section 133 of the Companies Act, 2013 read with Companies (Accounting Standards) as amended from time to time and other accounting principles generally accepted and in terms of SEBI (Listing Obligation and Disclosure Requirement) Regulations , 2015. <BR> 3 The Company was listed on the SME Platform of the National Stock Exchange of India Limited (NSE) on 8th December 2025 pursuant to an Initial Public Offer (IPO). Accordingly, these are the first financial results submitted by the Company to the Stock Exchange in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. <BR> 4 The Company is listed on the SME Platform of NSE. Accordingly: <BR> a. The Company is permitted to prepare financial results under Accounting Standards (AS). <BR> b. Submission of financial results is on a half-yearly basis. <BR> 5 The figures for the half year ended 31 March 2026 and corresponding half year ended in previous year are the balancing figures between the audited figures in respect of the full year and the published year to date figures upto the end of 2nd half of the relevant financial year. Also, the figures upto the end of 1st half has only been reviewed and not subjected to audit. <BR> 6 Pursuant to the IPO, the Company has issued equity shares resulting in an increase in paid-up share capital. The post-issue capital structure is reflected in these financial results. <BR> 7 The company is engagged in the activity of the diagnostic center only in maharashtra state of india and therefore the company is operating under single segement due to which segment reporting is not required either based on nature of services or geographically. <BR> 8 Figures of the previous period / year have been regrouped/rearranged, wherever considered necessary. <BR> 9 Pursuant to the Initial Public Offer (IPO) of the Company and listing of equity shares on the SME Platform of the National Stock Exchange of India Limited, the comparative figures presented in the financial results have been aligned with the Restated Financial Statements prepared in accordance with the applicable provisions of the Companies Act, 2013, SEBI ICDR Regulations and applicable Accounting Standards. Accordingly, certain prior period balances have been adjusted/reclassified in the comparative figures to give effect to such restatement and presentation adjustments. <BR> 10 The Company’s investment in partnership firm(s)/LLP(s) is carried in the standalone financial statements at cost, subject to assessment for diminution/impairment, if any. The share of accumulated profit/(loss) pertaining to such partnership firm(s)/LLP(s), being retained within the respective entities and reflected in partners’ capital/current accounts, has not been separately recognised in the standalone financial results. The same has been considered appropriately in the consolidated financial statements, wherever applicable. <BR> <BR> 11 There were no investor complaints pending at the beginning or at the end of the period <BR> 12 This being the first financial results post listing, the Company is focused on scaling operations, improving margins, and strengthening governance frameworks in line with listed entity requirements. <BR> <BR> 13 The above financial results are available on the website of the Company at https://www.pcdiagnostics.in/ and website of Stock Exchange www.nseindia.com. <BR> 2025-04-012026-03-31AuditedStandalone20276600011325000214091000018130000-2410002930700042400014857000790730001415500007254100007254100014569000269100017260000055281000000055281000055281000125720000103652440005.565.56005.565.56Other Expenses39866000Other Expenses790730007415900000033000000166357000001663570000545700024600600038680000502600021208800006206200027917600006400002836840000052969000012572000036524400049096400049096400000108200081380009220000008617000861700086170005863000150260002950600038726000529690000Non Current Assets5457000Other current assets640000Other current liabilities5863000424000-241000188570000-61400000-4661700005780000025720000148570000-11310000015300000113250000000-892100000-26206000463350000001428200003205300000000000050984000086329000000000000000000011325000033000-125955000002983630000000000004240000029793900020403700002040370008039000212076000000000AuditedtrueKanak Rathod & Cotrue2029-02-28Public Issues2025-12-042812480002026-03-31falsefalsefalseNoneNoneSanket Vinod JainDirectorMumbai2026-05-18Issue related ExpensesNo293690000278590000Funding capital expenditure for purchase of medical equipment towards establishment of five new diagnostic centres in MaharashtraNo2111330000227790000Unutilized amount lying in Fixed deposit & Current account with banks <br></br> General Corporate purposesNo407460000238000000